The Valley Desk

NCT06290141 · Interventional trial

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Overall registry status Recruiting

Phase 3

Conditions Chronic Inflammatory Demyelinating Polyneuropathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov